CAMBRIDGE, Mass., Jan. 4,
2018 /PRNewswire/ -- Merrimack Pharmaceuticals (NASDAQ: MACK)
today announced that Richard Peters,
M.D., Ph.D., President and Chief Executive Officer, is scheduled to
present at the 36th Annual J.P. Morgan Healthcare
Conference on Thursday, January 11,
2018, at 9:00 a.m. PT in
San Francisco.
A live webcast of the presentation can be accessed under "Events
and Presentations" in the Investors section of the Company's
website at www.merrimack.com. A replay of the webcast will be
archived there for approximately 30 days following the
presentation.
About Merrimack
Merrimack is a biopharmaceutical
company based in Cambridge,
Massachusetts that is outthinking cancer to ensure that
patients and their families live fulfilling lives. Its mission is
to transform cancer care through the smart design and development
of targeted solutions based on a deep understanding of cancer
pathways and biological markers. All of Merrimack's development
programs, including four clinical studies and six candidates in
preclinical development, fit into its strategy of 1) understanding
the biological problems it is trying to solve, 2) designing
specific solutions and 3) developing those solutions for
biomarker-selected patients. This three-pronged strategy seeks to
ensure optimal patient outcomes. For more information, please visit
Merrimack's website at www.merrimack.com.
Forward Looking Statements
Any statements in this
press release about future expectations, plans and prospects for
Merrimack constitute forward-looking statements within the meaning
of The Private Securities Litigation Reform Act of 1995, as
amended. Actual results may differ materially from those indicated
by such forward-looking statements. Merrimack anticipates that
subsequent events and developments will cause its views to change.
However, while Merrimack may elect to update these forward-looking
statements at some point in the future, Merrimack specifically
disclaims any obligation to do so.
Contact:
Geoffrey
Grande, CFA
617-441-7602
ggrande@merrimack.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/merrimack-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300577037.html
SOURCE Merrimack Pharmaceuticals, Inc.